CIK 0001953530 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, Nasdaq · incorporated in V8 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-30 | 6-K | 6-K | 2026-09-30 |
| 2026-08-10 | 6-K | 6-K | 2026-08-10 |
| 2026-08-06 | S-8 | S-8 | |
| 2026-08-06 | 6-K | 6-K | 2026-06-30 |
| 2026-06-25 | 6-K | 6-K | 2026-06-25 |
| 2026-06-01 | 6-K | 6-K | 2026-05-29 |
| 2026-05-14 | 6-K | 6-K | 2026-05-14 |
| 2026-05-11 | 6-K | 6-K | 2026-03-31 |
| 2026-04-29 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-21 | 6-K | 6-K | 2026-04-21 |
| 2026-03-27 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-03-09 | 144 | 144 | |
| 2026-03-04 | 6-K | 6-K | 2026-03-04 |
| 2026-03-04 | F-3ASR | F-3ASR | |
| 2026-03-04 | 20-F | 20-F | 2025-12-31 |
| 2026-03-03 | 6-K | 6-K | 2026-03-03 |
| 2025-12-08 | EFFECT | EFFECT items ,, | |
| 2025-12-05 | POS AM | POS AM | |
| 2025-12-01 | 424B3 | 424B3 | |
| 2025-11-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2025-11-10 | F-3 | F-3 | |
| 2025-11-10 | 6-K | 6-K | 2025-11-10 |
| 2025-10-31 | 424B5 | 424B5 | |
| 2025-10-31 | 424B5 | 424B5 | |
| 2025-10-31 | 6-K | 6-K | 2025-10-31 |
Forms on file (last 1,000): 6-K 46, 424B3 12, CORRESP 11, UPLOAD 8, EFFECT 7, SCHEDULE 13G/A 6, SC 13G 6, 20-F 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=OCS (0.002 USD), /gw/filings/filings?ticker=OCS&form=8-K, /gw/filings/facts?ticker=OCS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange